EW
43
4
M
33
-4
BAX
32
2
NWSA
65
2
HES
62
-4
O
24
2
VRSK
80
3
K
59
2
HAL
62
2
HUM
43
-6
NEE
54
4
PM
64
2
HAS
37
4
PG
60
4
ESS
67
3
UA
65
15
ADSK
68
-2
NWS
64
2
ROK
66
4
PDCO
46
8
EW
43
4
M
33
-4
BAX
32
2
NWSA
65
2
HES
62
-4
O
24
2
VRSK
80
3
K
59
2
HAL
62
2
HUM
43
-6
NEE
54
4
PM
64
2
HAS
37
4
PG
60
4
ESS
67
3
UA
65
15
ADSK
68
-2
NWS
64
2
ROK
66
4
PDCO
46
8
Financhill
Back

Inovio Pharmaceuticals 10K Form

Sell
22

INO
Inovio Pharmaceuticals

Last Price:
4.01
Seasonality Move:
18.82%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive INO News And Ratings

See the #1 stock for the next 7 days that we like better than INO

INO Financial Statistics

Sales & Book Value

Annual Sales: $832.01K
Cash Flow: $-27.44M
Price / Cash Flow: 0
Annual Sales: $2.82
Price / Book: 1.47

Profitability

EPS (TTM): -4.47000
Net Income (TTM): $-112.88M
Gross Margin: $0
Return on Equity: 0%
Return on Assets: 0%

Inovio Pharmaceuticals Earnings Forecast

Key Inovio Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 18 years for INO is 0.00%.
  • The Selling, General & Administrative Expenses for INO have been equal to 5,718.93% of Gross Profit Margin.
  • The Research & Development expenses have been 10,417.73% of Revenue.
  • The Interest Expense is -0.90% of Operating Income.
  • The Net Earning history of INO is -16,239.87% of Total Revenues.
  • Per Share Earnings over the last 25 years have been positive in 13 years.

Inovio Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: INO
CUSIP: 45773H
Website: inovio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

INO Technical Analysis vs Fundamental Analysis

Sell
22
Inovio Pharmaceuticals (INO) is a Sell

Is Inovio Pharmaceuticals a Buy or a Sell?